Venture Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 Cr
- Satisfied Charges ₹ 2.18 Cr
- Revenue Growth -40.05%
- Profit Growth -85.21%
- Ebitda -33.95%
- Net Worth 3.62%
- Total Assets -41.10%
About Venture Pharmaceuticals
Venture Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2020 (Four years and 11 months 6 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.30 Cr. The company has closed loans amounting to ₹2.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hasmukhbhai Antala, Vinod Ranparia, and Sujitkumar Radadiya serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2020PTC112931
-
Company No.
112931
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Feb 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Venture Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hasmukhbhai Antala
|
Director | 25-Feb-2020 | Current |
|
Vinod Ranparia
|
Director | 25-Feb-2020 | Current |
|
Sujitkumar Radadiya
|
Director | 25-Feb-2020 | Current |
Financial Performance of Venture Pharmaceuticals.
Venture Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.05% decrease. The company also saw a substantial fall in profitability, with a 85.21% decrease in profit. The company's net worth moved up by a moderate rise of 3.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venture Pharmaceuticals?
In 2023, Venture Pharmaceuticals had a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aden Pharmaceuticals Private LimitedHasmukhbhai Antala is a mutual person
Charges (Loans)
₹1.30 Cr
₹2.18 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2023 | Hdfc Bank Limited | ₹1.30 Cr | Open |
| 20 Mar 2021 | Axis Bank Limited | ₹2.18 Cr | Satisfied |
How Many Employees Work at Venture Pharmaceuticals?
Unlock and access historical data on people associated with Venture Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venture Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venture Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
